Quantbot Technologies LP Buys 10,429 Shares of Cabot Corporation (CBT)
Quantbot Technologies LP increased its stake in shares of Cabot Corporation (NYSE:CBT) by 224.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,072 shares of the specialty chemicals company’s stock after acquiring an additional 10,429 shares during the quarter. Quantbot Technologies LP’s holdings in Cabot Corporation were worth $841,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently bought and sold shares of CBT. Teachers Advisors LLC grew its position in Cabot Corporation by 3.3% during the 1st quarter. Teachers Advisors LLC now owns 152,965 shares of the specialty chemicals company’s stock worth $9,164,000 after acquiring an additional 4,901 shares during the last quarter. Capstone Asset Management Co. grew its position in Cabot Corporation by 4.0% during the 2nd quarter. Capstone Asset Management Co. now owns 5,442 shares of the specialty chemicals company’s stock worth $291,000 after acquiring an additional 210 shares during the last quarter. Oregon Public Employees Retirement Fund grew its position in Cabot Corporation by 4.5% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 22,854 shares of the specialty chemicals company’s stock worth $1,221,000 after acquiring an additional 994 shares during the last quarter. LS Investment Advisors LLC grew its position in Cabot Corporation by 15.3% during the 2nd quarter. LS Investment Advisors LLC now owns 4,858 shares of the specialty chemicals company’s stock worth $260,000 after acquiring an additional 645 shares during the last quarter. Finally, Louisiana State Employees Retirement System grew its position in Cabot Corporation by 3.8% during the 2nd quarter. Louisiana State Employees Retirement System now owns 16,300 shares of the specialty chemicals company’s stock worth $871,000 after acquiring an additional 600 shares during the last quarter. Institutional investors and hedge funds own 84.77% of the company’s stock.
CBT has been the topic of several recent research reports. Zacks Investment Research lowered Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, November 7th. KeyCorp reiterated a “hold” rating on shares of Cabot Corporation in a report on Wednesday, November 1st. Jefferies Group LLC reiterated a “buy” rating and issued a $74.00 price objective on shares of Cabot Corporation in a report on Friday, November 3rd. ValuEngine cut Cabot Corporation from a “buy” rating to a “hold” rating in a report on Friday, July 28th. Finally, J P Morgan Chase & Co upgraded Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 price objective for the company in a report on Tuesday, August 15th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Cabot Corporation presently has a consensus rating of “Hold” and a consensus target price of $61.14.
In related news, insider Hobart Kalkstein sold 3,881 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $53.39, for a total transaction of $207,206.59. Following the completion of the transaction, the insider now owns 27,736 shares of the company’s stock, valued at approximately $1,480,825.04. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 2.50% of the stock is owned by company insiders.
Cabot Corporation (NYSE CBT) opened at $60.67 on Thursday. The company has a market capitalization of $3,787.32, a P/E ratio of 17.84, a PEG ratio of 1.62 and a beta of 1.11. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.70 and a quick ratio of 1.17. Cabot Corporation has a one year low of $50.21 and a one year high of $64.66.
Cabot Corporation (NYSE:CBT) last released its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 EPS for the quarter, missing the Zacks’ consensus estimate of $0.93 by ($0.02). The firm had revenue of $723.00 million during the quarter, compared to analysts’ expectations of $683.30 million. Cabot Corporation had a net margin of 8.87% and a return on equity of 15.11%. The company’s revenue for the quarter was up 16.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 EPS. analysts expect that Cabot Corporation will post 3.78 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Investors of record on Friday, November 24th will be given a dividend of $0.315 per share. This represents a $1.26 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date of this dividend is Wednesday, November 22nd. Cabot Corporation’s dividend payout ratio (DPR) is presently 33.07%.
Cabot Corporation Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT).
Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.